The 2 Minute Medicine® Podcast- Episode 51

This Pharma Roundup episode reviews four major regulatory and clinical developments shaping early 2026. It begins with the Food and Drug Administration approval of Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for uncomplicated gonorrhea offering a needle-free alter ...  Show more

In this episode, we lead with our article of the week from the New England Journal of Medicine examining the noninferiority of a single-dose HPV vaccine compared with the standard two-dose regimen. We then dive into a detailed edition of The Scan, discussing how oral semaglutide ...  Show more

It's a podcast of pairs this time, for the latest issue of the journal. There's two hosts, two halves of the brain, two sides to a clinical debate, and two themes to the episode itself. Leading off is a discussion on peripheral neurology, taking a look at the editors' choice p ...

Trial of the Week: PROWESS-SHOCK Special Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita 03:30 – Background studies/Setting the scene 30:25 – PROWESS-SHOCK discussion/Where are we now Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (a ...  Show more

FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professio ...  Show more

Gastric sleeve surgery is the key feature of a pair of recent cases from the journal, which start this episode (1:17). Both cases feature 25-yo women with presentations in common: paraesthesia and limb weakness, along with disordered eye movement. Their symptoms arose soon aft ...